Cargando…
PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides
PURPOSE: Due to the restricted expression of α(v)β(3) in tumours, α(v)β(3) is considered a suitable receptor for tumour targeting. In this study the α(v)β(3)-binding characteristics of (68)Ga-labelled monomeric, dimeric and tetrameric RGD peptides were determined and compared with their (111)In-labe...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005123/ https://www.ncbi.nlm.nih.gov/pubmed/20857099 http://dx.doi.org/10.1007/s00259-010-1615-x |
_version_ | 1782194070111649792 |
---|---|
author | Dijkgraaf, Ingrid Yim, Cheng-Bin Franssen, Gerben M. Schuit, Robert C. Luurtsema, Gert Liu, Shuang Oyen, Wim J. G. Boerman, Otto C. |
author_facet | Dijkgraaf, Ingrid Yim, Cheng-Bin Franssen, Gerben M. Schuit, Robert C. Luurtsema, Gert Liu, Shuang Oyen, Wim J. G. Boerman, Otto C. |
author_sort | Dijkgraaf, Ingrid |
collection | PubMed |
description | PURPOSE: Due to the restricted expression of α(v)β(3) in tumours, α(v)β(3) is considered a suitable receptor for tumour targeting. In this study the α(v)β(3)-binding characteristics of (68)Ga-labelled monomeric, dimeric and tetrameric RGD peptides were determined and compared with their (111)In-labelled counterparts. METHODS: A monomeric (E-c(RGDfK)), a dimeric (E-[c(RGDfK)](2)) and a tetrameric (E{E[c(RGDfK)](2)}(2)) RGD peptide were synthesised, conjugated with DOTA and radiolabelled with (68)Ga. In vitro α(v)β(3)-binding characteristics were determined in a competitive binding assay. In vivo α(v)β(3)-targeting characteristics of the compounds were assessed in mice with subcutaneously growing SK-RC-52 xenografts. In addition, microPET images were acquired using a microPET/CT scanner. RESULTS: The IC(50) values for the Ga(III)-labelled DOTA-E-c(RGDfK), DOTA-E-[c(RGDfK)](2) and DOTA-E{E[c(RGDfK)](2)}(2) were 23.9 ± 1.22, 8.99 ± 1.20 and 1.74 ± 1.18 nM, respectively, and were similar to those of the In(III)-labelled mono-, di- and tetrameric RGD peptides (26.6 ± 1.15, 3.34 ± 1.16 and 1.80 ± 1.37 nM, respectively). At 2 h post-injection, tumour uptake of the (68)Ga-labelled mono-, di- and tetrameric RGD peptides (3.30 ± 0.30, 5.24 ± 0.27 and 7.11 ± 0.67%ID/g, respectively) was comparable to that of their (111)In-labelled counterparts (2.70 ± 0.29, 5.61 ± 0.85 and 7.32 ± 2.45%ID/g, respectively). PET scans were in line with the biodistribution data. On all PET scans, the tumour could be clearly visualised. CONCLUSION: The integrin affinity and the tumour uptake followed the order of DOTA-tetramer > DOTA-dimer > DOTA-monomer. The (68)Ga-labelled tetrameric RGD peptide has excellent characteristics for imaging of α(v)β(3) expression with PET. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-010-1615-x) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-3005123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30051232011-01-19 PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides Dijkgraaf, Ingrid Yim, Cheng-Bin Franssen, Gerben M. Schuit, Robert C. Luurtsema, Gert Liu, Shuang Oyen, Wim J. G. Boerman, Otto C. Eur J Nucl Med Mol Imaging Original Article PURPOSE: Due to the restricted expression of α(v)β(3) in tumours, α(v)β(3) is considered a suitable receptor for tumour targeting. In this study the α(v)β(3)-binding characteristics of (68)Ga-labelled monomeric, dimeric and tetrameric RGD peptides were determined and compared with their (111)In-labelled counterparts. METHODS: A monomeric (E-c(RGDfK)), a dimeric (E-[c(RGDfK)](2)) and a tetrameric (E{E[c(RGDfK)](2)}(2)) RGD peptide were synthesised, conjugated with DOTA and radiolabelled with (68)Ga. In vitro α(v)β(3)-binding characteristics were determined in a competitive binding assay. In vivo α(v)β(3)-targeting characteristics of the compounds were assessed in mice with subcutaneously growing SK-RC-52 xenografts. In addition, microPET images were acquired using a microPET/CT scanner. RESULTS: The IC(50) values for the Ga(III)-labelled DOTA-E-c(RGDfK), DOTA-E-[c(RGDfK)](2) and DOTA-E{E[c(RGDfK)](2)}(2) were 23.9 ± 1.22, 8.99 ± 1.20 and 1.74 ± 1.18 nM, respectively, and were similar to those of the In(III)-labelled mono-, di- and tetrameric RGD peptides (26.6 ± 1.15, 3.34 ± 1.16 and 1.80 ± 1.37 nM, respectively). At 2 h post-injection, tumour uptake of the (68)Ga-labelled mono-, di- and tetrameric RGD peptides (3.30 ± 0.30, 5.24 ± 0.27 and 7.11 ± 0.67%ID/g, respectively) was comparable to that of their (111)In-labelled counterparts (2.70 ± 0.29, 5.61 ± 0.85 and 7.32 ± 2.45%ID/g, respectively). PET scans were in line with the biodistribution data. On all PET scans, the tumour could be clearly visualised. CONCLUSION: The integrin affinity and the tumour uptake followed the order of DOTA-tetramer > DOTA-dimer > DOTA-monomer. The (68)Ga-labelled tetrameric RGD peptide has excellent characteristics for imaging of α(v)β(3) expression with PET. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00259-010-1615-x) contains supplementary material, which is available to authorized users. Springer-Verlag 2010-09-21 2011 /pmc/articles/PMC3005123/ /pubmed/20857099 http://dx.doi.org/10.1007/s00259-010-1615-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Original Article Dijkgraaf, Ingrid Yim, Cheng-Bin Franssen, Gerben M. Schuit, Robert C. Luurtsema, Gert Liu, Shuang Oyen, Wim J. G. Boerman, Otto C. PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title | PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title_full | PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title_fullStr | PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title_full_unstemmed | PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title_short | PET imaging of α(v)β(3) integrin expression in tumours with (68)Ga-labelled mono-, di- and tetrameric RGD peptides |
title_sort | pet imaging of α(v)β(3) integrin expression in tumours with (68)ga-labelled mono-, di- and tetrameric rgd peptides |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005123/ https://www.ncbi.nlm.nih.gov/pubmed/20857099 http://dx.doi.org/10.1007/s00259-010-1615-x |
work_keys_str_mv | AT dijkgraafingrid petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT yimchengbin petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT franssengerbenm petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT schuitrobertc petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT luurtsemagert petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT liushuang petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT oyenwimjg petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides AT boermanottoc petimagingofavb3integrinexpressionintumourswith68galabelledmonodiandtetramericrgdpeptides |